Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DoubleVerify To Contact Him Directly To Discuss Their Options

Bank OZK delivered record Q2 earnings and robust loan growth, with deposits and loans both rising significantly, outpacing sector peers. Prudent underwriting and strong reserve coverage support manageable credit costs, despite commercial real estate exposure, and loan quality remains sound. OZK is diversifying its loan book away from real estate, maintaining a solid capital position, and rewarding shareholders with buybacks and a growing dividend.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sarepta To Contact Him Directly To Discuss Their Options

Across this year, shares of the “Magnificent Seven” have not traveled in the same direction.

Insiders are pouncing on these three Dividend Aristocrat stocks. All three stocks are at distressed valuations, with many investors seeing a turnaround.

The retail sales report for June showed a slight increase in consumer discretionary spending. One month doesn't make a pattern, but it's at least a temporary relief for companies that rely on consumers willing to stretch their budgets for their products and services.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In 3D Systems To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options

By Vanya Sharma, Senior Associate, Capital Markets Key Takeaways As equity markets remain volatile, WisdomTree's fixed income ETFs—like AGGY and SHAG—offer investors a way to anchor portfolios with higher-yielding, investment-grade exposure while managing interest rate risk.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Vestis To Contact Him Directly To Discuss Their Options

You can live off of dividends and still see outstanding returns from your portfolio. It's time to transition from a cashless retirement portfolio to a bountiful one. Your retirement will be expensive; solve your financial puzzle with this key piece.

Starting off a portfolio with $1,000 may seem overly modest, but it can be a great place to begin. The more challenging task is finding stocks that can turn $1,000 into a significantly larger sum without incurring excessive risk.

Key Points in This Article: Circle Internet Group‘s (CRCL) stock surged from $31 to nearly $200, driven by USDC's $61 billion market cap and regulatory tailwinds like the GENIUS Act.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fortrea To Contact Him Directly To Discuss Their Options

The cannabis industry continues expanding rapidly, especially online. Many consumers now rely on digital platforms to explore products and find local dispensaries. At the same time, ancillary sectors like technology, packaging, and paraphernalia have become essential. These businesses do not handle cannabis directly. Instead, they support the market from the sidelines. The U.S. cannabis industry is valued at over $45 billion in 2025. Analysts expect strong growth to continue over the next five years. As demand rises, so does the need for accessories and digital services. Retailers depend on software and secure packaging to stay compliant. Additionally, online traffic helps …

AI is a main theme of second-quarter earnings as Alphabet reports this week. Tesla, Mattel, Hasbro and Coca-Cola also report, as Trump policies remain top of mind.

Tesla opened the doors to its first showroom in India this week, and among the first visitors was Vishal Gondal — a longtime Tesla and Elon Musk loyalist who pre-booked a Model 3 in April 2016, just hours after reservations went live. But despite showing up on day one, Gondal says he has no plans to buy a Tesla now.

Merck (MRK -1.91%), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its famous cancer medicine.

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.